BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Healthcare

Segment
Pharmaceuticals





 Company News
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone For AVP-786 Under AVANIR Pharmaceuticals (AVNR) Collaboration 8/26/2014 9:28:38 AM
AVANIR Pharmaceuticals (AVNR) Announces Initiation Of Phase 2 Study Of AVP-786 For The Adjunctive Treatment Of Major Depressive Disorder 8/26/2014 7:32:22 AM
AVANIR Pharmaceuticals (AVNR) Reports Fiscal 2014 Third Quarter Financial And Business Update 8/6/2014 8:01:44 AM
AVANIR Pharmaceuticals (AVNR) To Participate In Two Conferences In August 8/5/2014 9:11:16 AM
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Third Quarter Financial Results And Conference Call 7/28/2014 8:50:47 AM
AVANIR Pharmaceuticals (AVNR) Announces FDA Acceptance Of IND For AVP-786 For The Adjunctive Treatment Of Major Depressive Disorder 7/21/2014 12:38:42 PM
AVANIR Pharmaceuticals (AVNR) Announces Presentation Of Positive Early Results From Prism II Study 7/16/2014 9:54:16 AM
AVANIR Pharmaceuticals (AVNR) Announces Two Data Presentations Related To Pseudobulbar Affect (PBA) At The Alzheimer's Association International Conference (AAIC) 7/1/2014 9:53:34 AM
AVANIR Pharmaceuticals (AVNR) Announces Three Data Presentations Related To AVP-825 For The Acute Treatment Of Migraine At The American Headache Society Annual Meeting 6/24/2014 7:17:19 AM
AVANIR Pharmaceuticals (AVNR)' Migraine Drug AVP-825 Meets Primary Endpoint in Phase 3 Trial 6/10/2014 6:29:28 AM
12345678910...